HEDIS® Results

Medicaid HEDIS® Annual Rates.

Molina’s scores for the past two years are below. You can see how Molina performs compared to our target goal.

Measure / Data Element

2019

2020

2020 Goal

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

57.99%

56.71%

67.47%

Adult BMI Assessment (ABA)

80.54%

85.93%

93.67%

Annual Dental Visits (ADV) Total

51.53%

53.00%

64.11%

Antidepressant Medication Management (AMM) Effective Continuation Phase Treatment

38.29%

38.64%

40.95%

Appropriate Testing for Pharyngitis (CWP)

80.25%

75.13%

86.51%

Appropriate Treatment for Upper Respiratory Infection (URI)

92.59%

87.82%

94.88%

Asthma Medication Ratio (AMR) Total

63.95%

62.30%

68.52%

Avoidance of Antibiotic Treatment for Acute Bronchitis / Bronchiolitis (AAB)

29.54%

41.20%

41.07%

Breast Cancer Screening (BCS)

50.21%

54.06%

63.98%

Cervical Cancer Screening (CCS)

59.85%

59.85%

66.49%

Childhood Immunization Status (CIS) Combination #10

31.14%

31.63%

42.02%

Chlamydia Screening in Women (CHL) Total

56.78%

58.83%

66.24%

Comprehensive Diabetes Care (CDC) BP Control < 140/90

63.99%

70.80%

71.44%

Comprehensive Diabetes Care (CDC) HbA1c Control < 8.0%

45.74%

50.85%

55.96%

Comprehensive Diabetes Care (CDC) Eye Exam

61.56%

63.02%

64.72%

Controlling High Blood Pressure (CBP)

56.69%

61.48%

66.91%

Diabetes Screening for People with Schizophrenia or Bipolar Disorder Who Are Using Antipsychotic Medications (SSD)

80.88%

80.56%

84.27%

Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence (FUA) 7-Day Follow-Up Total

16.91%

20.30%

16.93%

Follow-Up After Emergency Department Visit for Mental Illness (FUM) 7-Day Follow-Up Total

46.95%

48.99%

49.65%

Follow-Up After Hospitalization for Mental Illness (FUH) 7-Day Follow-Up Total

44.01%

43.35%

42.69%

Follow-Up for Children Prescribed ADHD Medication (ADD) Continuation and Maintenance Phase

57.93%

62.01%

62.69%

Immunizations for Adolescents (IMA) Combination #2

25.55%

33.46%

40.39%

Initiation and Engagement of Alcohol and Other Drug Dependence Treatment (IET) Engagement of AOD Treatment Rate Total

24.95%

22.80%

18.12%

Medication Management for People with Asthma (MMA) Medication Compliance 75% Total

40.93%

41.85%

42.77%

Metabolic Monitoring for Children and Adolescents on Antipsychotics (APM) Total

30.51%

31.86%

40.90%

Pharmacotherapy Management of COPD Exacerbation (PCE) Systemic Corticosteroids

76.53%

76.44%

75.38%

Pharmacotherapy Management of COPD Exacerbation (PCE) Bronchodilator

85.55%

85.17%

87.93%

Prenatal and Postpartum Care (PPC) Timeliness of Prenatal Care

82.97%

98.54%

87.59%

Prenatal and Postpartum Care (PPC) Postpartum Care

67.40%

79.81%

69.83%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Received Statin Therapy Total

81.76%

82.13%

81.24%

Statin Therapy for Patients with Cardiovascular Disease (SPC) Statin Adherence 80% Total

60.98%

66.05%

69.97%

Statin Therapy for Patients with Diabetes (SPD) Received Statin Therapy

67.37%

68.53%

67.19%

Statin Therapy for Patients with Diabetes (SPD) Statin Adherence 80%

60.75%

64.85%

66.42%

Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Total

75.88%

78.71%

66.58%

Use of Imaging Studies for Low Back Pain (LBP)

63.84%

68.44%

76.02%

Use of Opioids at High Dosage (HDO)

2.56%

3.07%

≤ 2.27%

Use of Opioids from Multiple Providers (UOP) Multiple Prescribers and Multiple Pharmacies

2.63%

2.05%

≤ 2.14%

Weight Assessment and Counseling for Nutrition and Physical Activity for Children/Adolescents (WCC) BMI Percentile

67.88%

72.51%

85.16%

 

NA = Not Available Due to Small Denominator
NB = No Benefit
NR = Not Reported
NQ = Not Required
BR = Biased Rate